Germline variation in pdcd1 is associated with overall survival in patients with metastatic melanoma treated with anti‐pd‐1 monotherapy

Autor: Mirjam de With, Daan P. Hurkmans, Esther Oomen-de Hoop, Ayoub Lalouti, Sander Bins, Samira El Bouazzaoui, Mandy van Brakel, Reno Debets, Joachim G. J. V. Aerts, Ron H. N. van Schaik, Ron H. J. Mathijssen, Astrid A. M. van der Veldt

Publikováno v: Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1370, p 1370 (2021)
Cancers, 13(6):1370, 1-13. Multidisciplinary Digital Publishing Institute (MDPI)

A substantial number of melanoma patients do not benefit from therapy with anti-PD-1. Therefore, we investigated the predictive value of single nucleotide polymorphisms (SNPs) in genes related to the PD-1 axis in patients with metastatic melanoma. Fr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1264313c6548e905b07d06e7e1f46b
https://doi.org/10.3390/cancers13061370